{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:11:48Z","timestamp":1792606308929,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.det.2008.07.006","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T08:17:58Z","timestamp":1225354678000},"page":"33-42","source":"Crossref","is-referenced-by-count":41,"title":["Optimizing Use of Oral Antibiotics in Acne Vulgaris"],"prefix":"10.1016","volume":"27","author":[{"given":"James Q.","family":"Del Rosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2008.07.006_bib1","series-title":"Year book of dermatology","first-page":"49","article-title":"Statistics of interest to the dermatologist","author":"Weinstock","year":"2007"},{"issue":"14","key":"10.1016\/j.det.2008.07.006_bib2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Clinical practice. Acne","volume":"352","author":"James","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib3","first-page":"589","article-title":"Pediatric acne: clinical presentations, evaluation, and management","volume":"6","author":"Krakowski","year":"2007","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.det.2008.07.006_bib4","first-page":"1","article-title":"Psychosocial impact of acne vulgaris: evaluating the evidence","volume":"9","author":"Tan","year":"2004","journal-title":"Skin Therapy Lett"},{"issue":"1","key":"10.1016\/j.det.2008.07.006_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.2004.06078.x","article-title":"Anger and acne: implications for quality of life, patient satisfaction and clinical care","volume":"151","author":"Rapp","year":"2004","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.sder.2005.03.001","article-title":"Insights in the pathogenic potential of Propionibacterium acnes from its complete genome","volume":"24","author":"Bruggemann","year":"2005","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2008.07.006_bib7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2004.01.023","article-title":"An update on the pathogenesis and management of acne vulgaris","volume":"51","author":"Harper","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib8","first-page":"582","article-title":"The Propionibacterium acnes genome: from the laboratory to the clinic","volume":"6","author":"Rosen","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.sder.2005.03.002","article-title":"The role of toll like receptors in the pathophysiology of acne","volume":"24","author":"McInturff","year":"2005","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.sder.2005.03.004","article-title":"The role of inflammation in the pathogenesis of acne and acne scarring","volume":"24","author":"Holland","year":"2005","journal-title":"Semin Cutan Med Surg"},{"issue":"6S","key":"10.1016\/j.det.2008.07.006_bib11","first-page":"9","article-title":"Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders","volume":"79","author":"Leyden","year":"2007","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.det.2008.07.006_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib13","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.det.2007.01.012","article-title":"Anti-inflammatory activity of tetracyclines","volume":"25","author":"Webster","year":"2007","journal-title":"Dermatol Clin"},{"issue":"6S","key":"10.1016\/j.det.2008.07.006_bib15","first-page":"6","article-title":"Report from the scientific panel on antibiotic use in dermatology: introduction","volume":"79","author":"Del Rosso","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.det.2008.07.006_bib16","article-title":"Update from the scientific panel on antibiotic use in dermatology: introduction","author":"Del Rosso","year":"2008","journal-title":"Cutis"},{"issue":"4S","key":"10.1016\/j.det.2008.07.006_bib17","first-page":"4","article-title":"Extended-release minocycline\u2014first systemic antibiotic approved for the treatment of acne: introduction","volume":"78","author":"Leyden","year":"2006","journal-title":"Cutis"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib18","first-page":"113","article-title":"Recently approved systemic therapies for acne vulgaris and rosacea","volume":"80","author":"Del Rosso","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.det.2008.07.006_bib19","first-page":"234","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","author":"Bikowski","year":"2003","journal-title":"SkinMed"},{"issue":"9","key":"10.1016\/j.det.2008.07.006_bib20","first-page":"2123","article-title":"Diagnosis and treatment of acne","volume":"69","author":"Feldman","year":"2004","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.292.6.726","article-title":"Treatment of acne vulgaris","volume":"292","author":"Haider","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.det.2008.07.006_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14656566.6.3.409","article-title":"Acne vulgaris: a review of antibiotic therapy","volume":"6","author":"Tan","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.det.2008.07.006_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2133.2001.03956.x","article-title":"Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatologic clinics in Europe, the USA, Japan and Australia","volume":"144","author":"Ross","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2008.07.006_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00128071-200304120-00002","article-title":"Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers","volume":"4","author":"Eady","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.det.2008.07.006_bib26","first-page":"873","article-title":"Common and alternative oral therapies for acne vulgaris : a review","volume":"6","author":"Amin","year":"2007","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib27","first-page":"430","article-title":"Oral trimethoprim-sulfamethoxazole in the treatment of acne vulgaris","volume":"79","author":"Bhambri","year":"2007","journal-title":"Cutis"},{"issue":"14","key":"10.1016\/j.det.2008.07.006_bib28","first-page":"217","article-title":"Azithromycin versus tetracycline in the treatment of acne vulgaris","volume":"17","author":"Rafiei","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/sder.2001.28207","article-title":"The evolving role of Propionibacterium acnes in acne","volume":"20","author":"Leyden","year":"2001","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.det.2008.07.006_bib30","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1067\/S0190-9622(03)01154-X","article-title":"A review of the use of combination therapies for the treatment of acne vulgaris","volume":"49","author":"Leyden","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"1S","key":"10.1016\/j.det.2008.07.006_bib31","first-page":"5","article-title":"The impact and importance of resistance","volume":"80","author":"Tanghetti","year":"2007","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib32","first-page":"616","article-title":"Study results of benzoyl peroxide 5%\/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris","volume":"6","author":"Del Rosso","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib35","unstructured":"Leyden JJ, Plott T, Wortzman M. Antibiotic-resistant P. acnes are suppressed by a 6% benzoyl peroxide wash. 31st Hawaii Dermatology Seminar. Wailea, Maui, Hawaii. March 3-9, 2007 [Poster]."},{"issue":"6S","key":"10.1016\/j.det.2008.07.006_bib36","first-page":"6","article-title":"Antibiotic resistance in the topical treatment of acne vulgaris","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2008.07.006_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1994.tb08519.x","article-title":"Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients","volume":"131","author":"Eady","year":"1994","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.det.2007.01.001","article-title":"Status report on antibiotic resistance: implications for the dermatologist","volume":"25","author":"Del Rosso","year":"2007","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.det.2008.07.006_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(83)70005-8","article-title":"Propionibacterium acnes resistance to antibiotics in acne patients","volume":"8","author":"Leyden","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"6877","key":"10.1016\/j.det.2008.07.006_bib40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.306.6877.555","article-title":"Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic use","volume":"306","author":"Eady","year":"1993","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.det.2008.07.006_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000067822","article-title":"Propionibacterium acnes resistance: a worldwide problem","volume":"206","author":"Eady","year":"2003","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2008.07.006_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2133.2001.04119.x","article-title":"Antibiotics in acne: time for a rethink","volume":"144","author":"Simpson","year":"2001","journal-title":"Br\u00a0J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2008.07.006_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.1998.tb140250.x","article-title":"Systematic review of Propionibacterium acnes resistance to systemic antibiotics","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.det.2008.07.006_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/09546630510011838","article-title":"Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment","volume":"16","author":"Thevarajah","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"1S","key":"10.1016\/j.det.2008.07.006_bib45","first-page":"3","article-title":"Antibiotic resistance and the role of combination acne therapy: introduction","volume":"80","author":"Tanghetti","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.det.2008.07.006_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.1989.tb01399.x","article-title":"Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure","volume":"121","author":"Eady","year":"1989","journal-title":"Br J Dermatol"},{"issue":"9452","key":"10.1016\/j.det.2008.07.006_bib47","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(04)17591-0","article-title":"Comparison of five antimicrobial regimens for treatment of mild to moderate facial acne vulgaris in the community: randomized controlled trial","volume":"364","author":"Ozolins","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.07.006_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.06614.x","article-title":"Treatment of acne with topical antibiotics: lessons from clinical studies","volume":"153","author":"Simonart","year":"2005","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib49","first-page":"607","article-title":"Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris","volume":"6","author":"Schlessinger","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2008.07.006_bib50","first-page":"48","article-title":"The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin topical gel 1% for the treatment of acne vulgaris","volume":"4","author":"Shalita","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"4S","key":"10.1016\/j.det.2008.07.006_bib51","first-page":"21","article-title":"Safety and efficacy of a new extended-release formulation of minocycline","volume":"78","author":"Fleischer","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.det.2008.07.006_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2008.07.006_bib53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2133.1999.03132.x","article-title":"Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris","volume":"141","author":"Cunliffe","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2008.07.006_bib54","first-page":"625","article-title":"A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris","volume":"6","author":"Campbell","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"4S","key":"10.1016\/j.det.2008.07.006_bib55","first-page":"7","article-title":"Systemic therapy for rosacea: focus on oral antibiotic therapy and safety","volume":"66","author":"Del Rosso","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.det.2008.07.006_bib56","series-title":"Comprehensive dermatologic drug therapy","first-page":"977","article-title":"Cutaneous drug reactions associated with systemic features","author":"Knowles","year":"2007"},{"key":"10.1016\/j.det.2008.07.006_bib57","series-title":"Comprehensive dermatologic drug therapy","first-page":"901","article-title":"Hematologic toxicity of drug therapy","author":"Remlinger","year":"2007"},{"key":"10.1016\/j.det.2008.07.006_bib58","first-page":"6","article-title":"The parable of the piano teacher","author":"Feldman","year":"2007","journal-title":"Skin and Aging."},{"key":"10.1016\/j.det.2008.07.006_bib59","first-page":"83","article-title":"Keeping it clean: a look at the clinical benefits of newer formulations of therapeutic cleansers for acne, rosacea and seborrheic dermatitis","author":"Del Rosso","year":"2003","journal-title":"Skin and Aging."},{"key":"10.1016\/j.det.2008.07.006_bib60","unstructured":"Walker C, Bradshaw M. The effect of oral doxycycline 100 mg once daily for 14 days on the nasopharyngeal flora of healthy volunteers: a preliminary analysis. Fall Clinical Dermatology, Las Vegas, Nevada, October 18\u201321, 2007 [Poster]."},{"key":"10.1016\/j.det.2008.07.006_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide resistant streptococci in healthy volunteers: a randomized, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.det.2008.07.006_bib62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863508000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863508000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:37:52Z","timestamp":1557880672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863508000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0733863508000624"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2008.07.006","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}